Using both in vivo and in vitro models, we demonstrated that PRMT5 can facilitate EMT and lymph-node metastasis of laryngeal carcinoma cells via modulating the Wnt4/β-catenin pathway. The gene discussed is PRMT5; the disease is laryngeal carcinoma.